DA-5218

DA-5218 · Dong-A ST Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DA-5218, covering 2025-11-17 to 2025-11-17. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of DA-5218 in Patients With Type 2 Diabetes [Phase 4]